Jagsonpal Pharma

{
  "main_header": {
    "sid": 134241,
    "name": "Jagsonpal Pharma",
    "stock_name": "Jagsonpal Pharma",
    "full_name": "Jagsonpal Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/jagsonpal-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "184.69",
    "chg": 0.34,
    "chgp": "0.18%",
    "dir": 1,
    "prev_price": "184.35",
    "mcapval": "1,226.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 507789,
    "symbol": "JAGSNPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE048B01035",
    "curr_date": "Mar 27",
    "curr_time": "",
    "bse_nse_vol": "1.6 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 27, 2026",
    "traded_date_str": "2026 03 27",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jagsonpal-pharma-134241-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-sell-3902884",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JagsonpalPharma_mojoScore_3902884.png",
        "date": "2026-03-20 10:10:03",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3884227",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JagsonpalPharma_technicaldot_3884227.png",
        "date": "2026-03-11 08:00:17",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a 4.24% gain on the day, the stock’s overall momentum and technical indicators suggest a cautious outlook, with a recent downgrade from Hold to Sell by MarketsMOJO underscoring the evolving market sentiment."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-sell-3879086",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JagsonpalPharma_mojoScore_3879086.png",
        "date": "2026-03-09 10:10:18",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-sell-3879070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JagsonpalPharma_mojoScore_3879070.png",
        "date": "2026-03-08 10:10:14",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Valuation Shifts Signal Growing Price Caution",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-valuation-shifts-signal-growing-price-caution-3867954",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JagsonpalPharma_valuationdot_3867954.png",
        "date": "2026-03-04 08:00:07",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting changing market perceptions amid broader sector volatility. Despite robust operational metrics, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a recalibration of price attractiveness relative to peers and historical averages."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-sell-3855267",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JagsonpalPharma_mojoScore_3855267.png",
        "date": "2026-02-25 10:10:25",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-sell-3839144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JagsonpalPharma_mojoScore_3839144.png",
        "date": "2026-02-14 10:10:18",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Valuation Shifts Signal Price Attractiveness Change",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-valuation-shifts-signal-price-attractiveness-change-3827684",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JagsonpalPharma_valuationdot_3827684.png",
        "date": "2026-02-09 08:00:13",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and impacts the stock’s price attractiveness relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-sell-3817978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JagsonpalPharma_mojoScore_3817978.png",
        "date": "2026-02-03 10:10:04",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with the most recent insights into the company’s performance and outlook."
      }
    ],
    "total": 234,
    "sid": "134241",
    "stock_news_url": "https://www.marketsmojo.com/news/jagsonpal-pharmaceuticals-134241"
  },
  "announcements": [
    {
      "details": "Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr ASHOK KUMAR PATI as Additional Non-Executive Independent Director of the company w.e.f. November 14, 2019.",
      "source": "NSE",
      "caption": "Jagsonpal Pharmaceuticals Limited - Appointment",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Jagsonpal Pharmaceuticals Limited - Outcome of Board Meeting",
      "datetime": "15-Nov-2019"
    },
    {
      "details": " <table><tr><td>The Exchange had sought clarification from Jagsonpal Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed. </td></tr></table>",
      "source": "NSE",
      "caption": "Reply to Clarification- Financial results",
      "datetime": "19-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has declared <strong>125%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has announced <strong>2:5</strong> stock split, ex-date: 08 Jan 25",
          "dt": "2025-01-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jagsonpal Pharmaceuticals Ltd is Rated Sell

2026-03-20 10:10:03

Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-03-11 08:00:17

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a 4.24% gain on the day, the stock’s overall momentum and technical indicators suggest a cautious outlook, with a recent downgrade from Hold to Sell by MarketsMOJO underscoring the evolving market sentiment.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Sell

2026-03-09 10:10:18

Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Sell

2026-03-08 10:10:14

Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd Valuation Shifts Signal Growing Price Caution

2026-03-04 08:00:07

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting changing market perceptions amid broader sector volatility. Despite robust operational metrics, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a recalibration of price attractiveness relative to peers and historical averages.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Sell

2026-02-25 10:10:25

Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Sell

2026-02-14 10:10:18

Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd Valuation Shifts Signal Price Attractiveness Change

2026-02-09 08:00:13

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and impacts the stock’s price attractiveness relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Sell

2026-02-03 10:10:04

Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with the most recent insights into the company’s performance and outlook.

Read full news article

View All News